chr1-201359212-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PM4
The NM_001276345.2(TNNT2):c.895T>C(p.Ter299Glnext*?) variant causes a stop lost change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. *299*) has been classified as Likely benign.
Frequency
Consequence
NM_001276345.2 stop_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Cardiovascular phenotype Uncertain:1
The p.*289QEXT*42 variant (also known as c.865T>C), located in coding exon 15 of the TNNT2 gene, results from a T to C substitution at nucleotide position 865, which is the last nucleotide of the TNNT2 gene. The stop codon at position 289 is replaced by glutamine, resulting in an elongation of the protein by 42 amino acids. This change occurs at the 3' terminus of TNNT2, is not expected to trigger nonsense-mediated mRNA decay, and results in the elongation of the protein by 42 amino acids. The exact functional impact of these inserted amino acids is unknown at this time. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.